Clinical Trials in Pennsylvania

Showing 6721-6740 of 14,950 trials

Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation

NCT04112849

The study objective is to measure the value of the third heart sound (S3) for the prediction of recurrent heart failure (HF). For the purpose of this study, a heart failure event will be defined as a hospitalization with a primary diagnosis of heart failure. The main hypothesis of the study is that measurement of S3, using a microelectronic machine microphone positioned in a wearable device (Nanowear Wearable Congestive Heart Failure Management System) near the time of discharge from a hospitalization for heart failure, can predict which patients will be at high risk for a heart failure event, thereby identifying a group in whom increased surveillance and monitoring may decrease hospital readmissions for worsening heart failure.

Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction

Milton S. Hershey Medical Center28 participantsStarted Mar 2020

Hershey, Pennsylvania, United States

COMPLETEDPhase 365 miles

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

NCT02990806

The purpose of this study was to demonstrate similarity of NI-071 (proposed biosimilar to infliximab) to US REMICADE® (reference product) in terms of safety and efficacy in participants with rheumatoid arthritis (RA) not adequately responding to methotrexate (MTX).

Rheumatoid Arthritis

Nichi-Iko Pharmaceutical Co., Ltd.683 participantsStarted Jan 2017

Little Rock, Arkansas, United States • Los Angeles, California, United States • Los Angeles, California, United States +131 more locations

Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

Find Trials by Condition in Pennsylvania

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Outcome pRognostication of Acute Brain Injury With the NeuroloGical Pupil indEx

Exercise Trial in Chronic Kidney Disease

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief

Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.

Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Rectal Microbicide Acceptability, Tolerability and Adherence

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Neuro RX Gamma - Pivotal Phase

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

Cholangioscopy in Primary Sclerosing Cholangitis (PSC)

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications